Latest news
New heart drug targeting inflammation falls short in clinical trial - Cardiovascular BusinessCardiovascular Business · Thu, 06 Aug 2026 20:22:24 GMTNovo Nordisk Q2'26: ZEUS failure overshadows obesity pipeline advances - AllSciAllSci · Thu, 06 Aug 2026 11:38:14 GMTNovo Nordisk Says Anti-Inflammatory Drug Trial Fails to Cut Cardiovascular Risk in High Risk Patients - BenzingaBenzinga · Fri, 31 Jul 2026 13:32:27 GMTNovo drug trial fail deals setback to bid to expand beyond obesity - 101 WIXX101 WIXX · Fri, 31 Jul 2026 12:43:42 GMTNovo Nordisk’s anti-inflammatory drug fails to reduce cardiovascular risk in late-stage trial - SRN NewsSRN News · Fri, 31 Jul 2026 12:41:25 GMTNovo Nordisk inflammation-targeting drug misses mark in heart disease study - STATSTAT · Fri, 31 Jul 2026 07:00:00 GMTNovo Nordisk drops as anti-inflammatory drug fails in late-stage trial - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 07:00:00 GMTInflammation Keeps Us Alive. It's Also Making Us Sick. - The New York TimesThe New York Times · Wed, 29 Jul 2026 07:00:00 GMT